Epidemiology of nosocomial bacteria resistant to antimicrobials

Colombia Medica

Volumn 42, Issue 1, 2011, Pages 117-125

  Cabrera, Cristina E ^a,b   Gómez, Romel F ^a   Zuñiga, Andrés E ^a   Corral, Raúl H ^a,b   López, Bertha ^c   Chávez, Mónica ^a,d  

^a UNIVERSIDAD LIBRE   (Colombia)

^b UNIVERSIDAD DEL VALLE   (Colombia)

^c Nuestra Senõra de Los Remedios Clínica Palma Real   (Colombia)

^d UNIVERSIDAD SANTIAGO DE CALI   (Colombia)

Author keywords

Antibiotics; Bacterial resistance; Epidemiology; Genetic diversity; Molecular epidemiology; Nosocomial infections

Indexed keywords

AMIKACIN; AMINOCYCLINE; AMINOGLYCOSIDE; ANTIBIOTIC AGENT; CARBAPENEM; CEFTRIAXONE; CIPROFLOXACIN; DOXYCYCLINE; ERYTHROMYCIN; EXTENDED SPECTRUM BETA LACTAMASE; GENTAMICIN; IMIPENEM; MEROPENEM; OXACILLIN; POLYMYXIN B; RIFAMPICIN; SULBACTAM; TETRACYCLINE DERIVATIVE; TOBRAMYCIN; UNCLASSIFIED DRUG;

ACINETOBACTER BAUMANNII; ANTIBIOTIC RESISTANCE; BACTERIUM ISOLATE; COLOMBIA; CROSS INFECTION; ENTEROBACTERIACEAE; ENTEROCOCCUS; ENTEROCOCCUS FAECIUM; GENETIC VARIABILITY; HOSPITAL INFECTION; HOSPITALIZATION; KLEBSIELLA PNEUMONIAE; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MOLECULAR EPIDEMIOLOGY; PSEUDOMONAS AERUGINOSA; REVIEW; SOUTH AND CENTRAL AMERICA; STAPHYLOCOCCUS AUREUS; VANCOMYCIN RESISTANT ENTEROCOCCUS;

EID: 79953015498     PISSN: 01208322     EISSN: 16579534     Source Type: Journal    
DOI: 10.25100/cm.v42i1.759     Document Type: Review

References (62)

1. Jones RN. Pathogens: Trends over the past few years resistance patterns among nosocomial. Chest. 2001; 119: 397-404.
2. Chambers HF, DeLeo FR. Waves of resistance: Staphylococcus aureus in the antibiotic era. Nat Rev Microbiol. 2009; 7: 629-41.
3. Leavis HL, Bonten MJ, Willems RJ. Identification of highrisk enterococcal clonal complexes: global dispersion and antibiotic resistance. Curr Opin Microbiol. 2006; 9: 454-60. (Pubitemid 44397629)
4. Schwaber MJ, Navon-Venezia S, Schwartz D, Carmeli Y. High levels of antimicrobial coresistance among extended-spectrum- α-lactamase-producing Enterobacteriaceae. Antimicrob. Agents Chemother. 2005; 49: 2137-9.
5. Thomson KS, Smith ME. The new α-lactamases of Gramnegative bacteria at the dawn of the new millennium. Microb Infect. 2000; 2: 1225-35.
6. Riccio ML, Franceschini N, Boschi L, Caravelli B, Cornaglia G, Fontana R, et al. Characterization of the metallo-α-lactamase determinant of Acinetobacter baumannii AC-54/97 reveals the existence of bla (IMP) allelic variants carried by gene cassettes of different phylogeny. Antimicrob Agents Chemother. 2000; 44: 1229-35.
7. Fluit ADC, Visser MR, Schmitz FJ. Molecular detection of antimicrobial resistance. Clin Microbiol Rev. 2001; 14: 836-71. (Pubitemid 32982145)
8. Johnson AP, Duckworth G, Pearson A. Surveillance and epidemiology of MRSA bacteraemia in the UK. J Antimicrob Chemother. 2005; 56: 455-62.
9. Pearson A, Chronias A, Murria M. Voluntary and mandatory surveillance for methicillin-resistant Staphylococcus aureus (MRSA) and methicillin-susceptible S. aureus (MSSA) bacteraemia in England. J Antimicrob Chemother. 2009; 64 (Supl 1): i11-i17.
10. Argudín MA, Mendoza MC, Méndez FJ, Martín MC, Guerra B, Rodicio MR. Clonal complexes and diversity of exotoxin gene profiles in methicillin-resistant and methicillin-susceptible Staphylococcus aureus isolates from patients in a Spanish hospital. J Clin Microbiol. 2009; 47: 2097-105.
11. Benfield T, Espersen F, Frimodt-Moller N, Jensen AG, Larsen AR, Pallesen LV, et al. Increasing incidence but decreasing in-hospital mortality of adult Staphylococcus aureus bacteraemia between 1981 and 2000. Clin Microbiol Infect. 2007; 13: 257-63.
12. Benquan W, Yingchun T, Kouxing Z, Tiantuo Z, Jiaxing Z, Shuqing T. Staphylococcus heterogeneously resistant to vancomycin in China and antimicrobial activities of imipenem and vancomycin in combination against It. J Clin Microbiol. 2002; 40: 1109-12. (Pubitemid 34208684)
13. Biedenbach DJ, Moet GJ, Jones RN. Occurrence and antimicrobial resistance pattern comparisons among bloodstream infection isolate from de SENTRY antimicrobial survillence programs (1997-2002). Diagn Microbiol Infect Dis. 2004; 50: 59-69.
14. Kennedy AD, Otto M, Braughton KR, Whitney AR, Chen L, Mathema B, et al. Epidemic community-associated methicillin-resistant Staphylococcus aureus: Recent clonal expansionand diversification. Proc Natl Acad Sci USA. 2008; 105: 1327-32. (Pubitemid 351397052)
15. Lester CH, Sandvang D, Olsen SS, Schonheyder HC, Jarlov JO, Bangsborg J. Emergence of ampicillin-resistant Enterococcus faecium in Danish hospitals. J Antimicrob Chemother. 2008; 62: 1203-6.
16. Schouten MA, Willems RJL, Kraak WAG, Top J, Hoogkamp- Korstanje JAA, Voss A. Molecular analysis of Tn1546-like elements in vancomycin-resistant enterococci isolated from patients in Europe shows geographic transposon type clustering. Antimicrob Agents Chemother. 2001; 45: 986-9. (Pubitemid 32182063)
17. Coque TM, Willems RJ, Fortun J, Top J, Diz S, Loza E, et al. Population structure of Enterococcus faecium causing bacteremia in a spanish university hospital: setting the scene for a future increase in vancomycin resistance? Antimicrob Agents Chemother. 2005; 49: 2693-700.
18. Ozawa Y, Tanimoto K, Nomura T, Yoshinaga M, Arakawam Y, Ike Y. Vancomycin-resistant enterococci in humans and imported chickensin Japan. Appl Environ Microbiol. 2002; 68: 6457-61. (Pubitemid 36342489)
19. Yu HS, Seol SY, Cho DT. Diversity of Tn1546-like elements in vancomycin-resistant enterococci isolated from humans and poultry in Korea. J Clin Microbiol. 2003; 41: 2641-3.
20. Babini GS, Livermore DM. Antimicrobial resistance amongs Klebsiella spp. colleted from intensive care units in Southern and Western Europe in 1997-1998. J Antimicrob Chemother. 2000; 45: 183-9. (Pubitemid 30095189)
21. Bagattini M, Crivaro V, Di Popolo A, Gentile F, Scarcella A, Triassi M, et al. Molecular epidemiology of extended-spectrum α-lactamase-producing Klebsiella pneumoniae in a neonatal intensive care unit. J Antimicrob Chemother. 2006; 57: 979-82.
22. Valverde A, Coque TM, García-San Miguel L, Baquero F, Canto R. Complex molecular epidemiology of extendedspectrum α-lactamases in Klebsiella pneumoniae: a long-term perspective from a single institution in Madrid. J Antimicrob Chemother. 2008; 61: 64-72.
23. Livermore DM, Canton R, Gniadkowsk M, Nordmann P, Rossolini GM, Arlet G, et al. CTX-M: changing the face of ESβLs in Europe. J Antimicrob Chemother. 2007; 59: 165-74. (Pubitemid 47072053)
24. Wei ZQ, Du XX, Yu YS, Shen P, Chen YG, Li LJ. Plasmid-mediated KPC-2 in a Klebsiella pneumoniae isolate from China. Antimicrob Agents Chemother. 2007; 51: 763-76.
25. Gangoue-Pieboji J, Miriagou V, Vourli S, Tzelepi E, Ngassam P, Tzouvelekis LS. Emergence of CTX-M-15-producing enterobacteria in Cameroon and characterization of a blaCTXM- 15-carrying element. Antimicrob Agents Chemother. 2005; 49: 441-3. (Pubitemid 40065828)
26. Kitchel B, Rasheed K, Patel JB, Srinivasan A, Navon-Venezia S, Carmeli Y, et al. Molecular epidemiology of KPC-producing Klebsiella pneumoniae isolates in the United States: clonal expansion of multilocus sequence type 258. Antimicrob Agents Chemother. 2009; 53: 3365-70.
27. Blanco M, Alonso MP, Nicolas-Chanoine MH, Dahbi G, Mora A, Blanco JE, et al. Molecular epidemiology of Escherichia coli producing extended-spectrum α-lactamases in Lugo (Spain): dissemination of clone O25b:H4-ST131 producing CTX-M-15. J Antimicrob Chemother. 2009; 63: 1135-41.
28. Lavollay M, Mamlouk K, Frank T, Akpabie A, Burghoffer B, Redjeb S, et al. Clonal dissemination of a CTX-M-15-β- lactamase-producing Escherichia coli strain in the Paris area, Tunis, and Bangui. Antimicrob Agents Chemether. 2006; 50: 2433-8.
29. Smith ME, Black JA, Hossain A, Hanson ND, Thomson KS, Pottumarthy S. Discovery of CTX-M-like extended-spectrum α-lactamases in Escherichia coli isolates from five US States. Antimicrob Agents Chemother. 2003; 47: 2382-3. (Pubitemid 36753610)
30. Pitout JDD, Nordmann P, Laupland KB, Poirel L. Emergence of Enterobacteriaceae-producing extended-spectrum β- lactamases (ESβLs) in the community. J Antimicrob Chemother. 2005; 56: 52-9. (Pubitemid 41418336)
31. Hsueh PR, Teng LJ, Chen CY, Chen WH, Yu CJ, Ho SW, et al. Pandrug-resistant Acinetobacter baumannii causing nosocomial infections in a university hospital, Taiwan. Emerg Infect Dis. 2002; 8: 827-32.
32. Rice LB. Challenges in identifying new antimicrobial agents effective for treating infections with Acinetobacter baumannii and Pseudomonas aeruginosa. Clin Infect Dis. 2006; 43 (Suppl 2): S100-5.
33. Houang ET, Chu YW, Leung CM, Chu KY, Berlau J, Ng KC, et al. Epidemiology and infection control implications of Acinetobacter spp. in Hong Kong. J Clin Microbiol. 2001; 39: 228-34. (Pubitemid 32059596)
34. Van Dessel H, Dijkshoorn L, van der Reijden T, Bakker N, Paauw A, van den Broek P, et al. Identification of a new geographically widespread multiresistant Acinetobacter baumannii clone from European hospitals. Res Microbiol. 2004; 155: 105-12. (Pubitemid 38249559)
35. Quale J, Bratu S, Landman D, Heddurshetti R. Molecular epidemiology and mechanisms of carbapenem resistance in Acinetobacter baumannii endemic in New York City. Clin Infect Dis. 2003; 37: 214-20. (Pubitemid 36930352)
36. Jones A, Morgan D, Walsh A, Turton J, Livermore D, Pitt T, et al. Importation of multidrug-resistant Acinetobacter spp. infections with casualties from Iraq. Lancet Infect Dis. 2006; 6: 317-8. (Pubitemid 43737279)
37. Turton JF, Kaufmann ME, Gill MJ, Pike R, Scott PT, Fishbain J, et al. Comparison of Acinetobacter baumannii isolates from the United Kingdom and the United States that were associated with repatriated casualties of the Iraq conflict. J Clin Microbiol. 2006; 44: 2630-4. (Pubitemid 44092447)
38. Aires De Sousa M, Miragaia M, Santos I, Avila S, Adamson I, Casagrande S, et al. Three year assesment of methicillin-resistant Sthaphyloccus aureus clones in Latin America from 1996 to 1998. J Clin Microbiol. 2001; 39: 2197-205. (Pubitemid 32531481)
39. Velázquez MME, Aires de Sousa M, Echaniz AG, Solorzano SF, Miranda NG, Silva SJ, et al. Surveillance of methicillin-resistant Staphylococcus aureus in a pediatric hospital in Mexico City during a 7-year period (1997 to 2003): Clonal evolution and impact of infection control. J Clin Microbiol. 2004; 42: 3877-80.
40. Velazco E, Nieves B, Araque M, Calderas Z. Epidemiología de Staphylococcus aureus en una unidad de alto riesgo neonatal. Enferm Infecc Microbiol Clin. 2002; 20: 321-5.
41. Mayor L, Ortellado J, Menacho C, Lird G, Courtier C, Gardon C, et al. Molecular characterization of methicillin-resistant Staphylococcus aureus isolates collected in Asunción, Paraguay. J Clin Microbiol. 2007; 45: 2298-300. (Pubitemid 47203814)
42. Sola C, Cortés P, Saka HA, Córdoba MRSA Collaborative Study Group, Vindel A, Bocco JL. Evolution and molecular characterization of methicillin-resistant Staphylococcus aureus epidemic and sporadic clones in Cordoba, Argentina. J Clin Microbiol. 2006. 44: 192-200. (Pubitemid 43100600)
43. Ponessa A, Gambande T, All L. Enterococos vancomicina resistentes: colonización en pacientes hospitalizados, en Rosario, Argentina. Acta Bioquim Clin Latinoam. 2006; 40: 499-502. (Pubitemid 47234762)
44. Marovac J, Campos MI. Enterococcus faecium resistente a vancomicina. Rev Med Chile. 2000; 128: 685-6.
45. Velásquez J, Lizaraso F, Zetola N, Pamno O, Sánchez L, Wong W, et al. Vigilancia de la resistencia de enterococcus sp a la vigilancia y evaluacion in vitro de nuevas alternativas terapéuticas. Rev Soc Peru Med Int. 2002; 15: 1-5.
46. Sader HS, Gales AC, Casellas JM, Smayevsky J, Prado V, Palaveccino E, et al. Comparison of the antimicrobial susceptibilities of nosocomial bacteria among Latin American countries. Intersci Conf Antimicrob Agents Chemother. 2000; 20: 40-85.
47. Pallecchi L, Malossi M, Mantella A, Gotuzzo E, Trigoso C, Bartoloni A, et al. Detection of CTX-Mtype α-lactamase genes in fecal Escherichia coli from healthy children in Bolivia and Peru. Antimicrob Agents Chemother. 2004; 48: 4556-61. (Pubitemid 39577653)
48. Díaz P, Bello H, Domínguez M, Trabal N, Mella S, Zemelman R, et al. Resistencia a gentamicina, amikacina y ciprofloxacina en cepas hospitalarias de Klebsiella pneumoniae subespecie pneumoniae productoras de α-lactamasas de espectro extendido. Rev Med Chile. 2004; 132: 1173-8.
49. Barbolla RE, Centron D, Di Martino A, Maimone S, Salgueira C, Famiglietti A. Identification of an epidemic carbapenemresistant Acinetobacter baumannii strain at hospitals in Buenos Aires City. Diag Microbiol Infect Dis. 2003; 45: 261-4. (Pubitemid 36555676)
50. Sader HS, Jones RN, Gales AC, SilvaJB, Pignatari AC. SENTRY antimicrobial surveillance program report: Latin America and Brazilian results for 1997 through 2001. Braz J Infect Dis. 2004; 8: 25-79.
51. Álvarez C, Cortés J, Arango A, Correa C, Leal A, GREBO. Resistencia antimicrobiana en unidades de cuidado intensivo de Bogotá, Colombia, 2001-2003. Revista de Salud Pública [en línea] 2006, 8: [fecha de consulta: 12 de marzo de 2011] Disponible en: http://redalyc.uaemex. mx/redalyc/src/inicio/ ArtPdfRed.jsp?iCve=42289908
52. Leal AL, Eslava J, Álvarez C, Buitrago G, Méndez M, GREBO. Canales endémicos y marcadores de resistencia bacteriana, en instituciones de tercer nivel de Bogotá, Colombia. Revista de Salud Pública. 2006; 859-70. Disponible en: http://redalyc. uaemex.mx/redalyc/src/inicio/ArtPdfRed.jsp?iCve=42289906
53. Espinal PA, Mantilla JR, Saavedra CH, Leal AL, Alpuche C, Valenzuela EM. Epidemiología molecular de infección nosocomial por Klebsiella pneumoniae productora de β-lactamasas de espectro extendido. Biomedica. 2004; 24: 252-61.
54. Mantilla JR, Valenzuela EM, Gil CA, Leal AL. Caracterización molecular de Klebsiella pneumoniae productora de β- lactamasas de espectro estendido (βLEE) del tipo CTM-X-12. Infectio. 2004; 8: 143.
55. Pinzón J, Mantilla JR, Valenzuela EM, Fernández F, Álvarez CA, Osorio E. Caracterización molecular de aislamientos de Acinetobacter baumannii provenientes de la unidad de quemados de un hospital de tercer nivel de Bogotá. Infectio. 2006; 10: 71-8.
56. Suárez CJ, Kattán JN, Guzmán AM, Villegas MV. Mecanismos de resistencia a carbapenems en P. aeruginosa, Acinetobacter y Enterobacteriaceae y estrategias para su prevención y control. Infectio. 2006; 10: 85-93.
57. Gómes AR, Sánches I, Aires De Sousa M, Castañeda E, De Lencastre H. Molecular epidemiology of methicillin-resistant Staphylococcus aureus in Colombian hospitals: Dominance of a single unique multidrug-resistant clone. Microb Drug Resist. 2001; 7: 23-32. (Pubitemid 32294814)
58. Enright MC, Robinson DA, Randle G, Feil EJ, Grundmann H, Spratt BG. The evolutionary history of methicillin-resistant Staphylococcus aureus (MRSA). Proc Natl Acad Sci USA. 2002; 99: 7687-92. (Pubitemid 34568752)
59. Sá-Leão R, Santos I, Dias D, Peres I, Barros R, Lencastre H. Detection of an archaic clone of Staphylococcus aureus with low-level resistance to methicillin in a pediatric hospital in Portugal and in international samples: relics of a formerly widely disseminated strain? J Clin Micorbiol. 1999; 37: 1913-20. (Pubitemid 29235245)
60. Deshpande LM, Fritsche TR, Jones RN. Molecular epidemiology of selected multidrug-resistant bacteria: a global report from the SENTRY Antimicrobial Surveillance Program. Diagn Microbiol Infect Dis. 2004; 49: 231-6. (Pubitemid 39094612)
61. Gruteke P, Goessens W, Gils J, Peerbooms N, Lemmens-den Toom, M Santen-Verheuvel, et al. Patterns of resistance associated with integrons, the extended-spectrum lactamase SHV-5 gene, and a multidrug efflux pump of Klebsiella pneumoniae causing a nosocomial outbreak. J Clin Microbiol. 2000; 41: 1161-6. (Pubitemid 36307123)
62. Martins-Loureiro M, Aguiar de Moraes B, Lorenzato-Furtado de Mendonça V, Rocha-Quadra MR. Epidemiología molecular de cepas de Klebsiella pneumoniae productoras de α- lactamasas de espectro extendido aisladas de pacientes neonatos en una unidad de cuidados intensivos involucrados en casos de infección hospitalaria en Río de Janeiro. Brasil Rev Latinoam Microbiol. 2001; 43: 88-95.